SARS-CoV-2-associated cerebrovascular disease | IDR

SARS-CoV-2-associated cerebrovascular disease | IDR

The unprecedented coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in late December 2019 in Wuhan, China. SARS-CoV-2 rapidly spread throughout the world, leading to the introduction of lockdown measures in many countries. In pandemic scenarios like SARS-CoV-2, rapid information aggregation is vital. In the era of eHealth and data-driven medicine, publicly available symptom tracking tools offer scalable and efficient means to collect and analyze large amounts of information. Consequently, front-line providers can be updated with knowledge gained. Various improvements have been made in these applications in different countries during the SARS-CoV-2 pandemic. The most common symptoms associated with the SARS-CoV-2-infection are fever, cough, and fatigue. Anosmia (loss of smell) was one of the first apparent symptoms that varies significantly in COVID-19 patients. …
More on: www.news-medical.net